Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Wednesday, December 18, 2024.
Stock Region Penny Picks Watchlist Newsletter - Wednesday, December 18, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Please consult with a financial advisor before making any investment decisions.
$PLRZ - Polyrizon
Polyrizon is moving forward with its anticipated 2025 clinical trial for its PL-14 allergy blocker. The company also entered into a manufacturing agreement to support the initiative, signaling potential growth opportunities.
$CGTX - Cognition Therapeutics
Cognition Therapeutics shared positive results from its Phase 2 study of CT1812, a treatment aimed at addressing dementia with Lewy bodies. This development enhances its pipeline's potential in neurodegenerative diseases.
$CARA - Cara Therapeutics
Cara Therapeutics announced a merger agreement with Tvardi Therapeutics. Investors may want to keep an eye on this merger's progress for further updates on combined capabilities and synergies.
$TRNR - TRNR Interactive Strength Inc.
TRNR has secured commitments for 162 CLMBR units and entered an exclusive distribution agreement with Planet Fitness SAS for the French market, reflecting growing demand for its fitness solutions.
$MTVA - MetaVia
MetaVia revealed positive top-line results from its Phase 2a trial of DA-1241 in patients with presumed MASH. This milestone could strengthen its portfolio in tackling liver-related conditions.
$TCBP - TC BioPharm
TC BioPharm proposed a special dividend of 0.25 ADS per ADS held, pending shareholder approval at its general meeting on December 30. This announcement highlights the company’s focus on shareholder returns.
$QNRX - Quoin Pharmaceuticals
The company reported positive interim data from two Netherton Syndrome clinical studies, affirming ongoing progress in addressing rare dermatological conditions.
$CHRO - Channel Therapeutics
Channel Therapeutics shared efficacy data on its NaV1.7 inhibitor in a preclinical in vivo nerve block model, marking an important step in its pain management research.
$BIOA - BioAge Labs
BioAge has announced a multi-year collaboration with Novartis to discover novel therapies targeting age-related conditions, positioning itself as a key player in longevity science.
$WIMI - WiMi
WiMi unveiled its FPGA-based digital quantum computer verification technology. This innovation underscores its advancements in quantum computing and its potential impact on future tech landscapes.
$MTEK - Maris-Tech
Maris-Tech completed its development of Uranus-Drones technology and is preparing for large-scale delivery, signaling readiness for significant market expansion.
$UMAC - Unusual Machines
Maxim Group initiated coverage on Unusual Machines with a "Buy" rating and set a price target of $18. This endorsement highlights the firm's future growth potential in its sector.
$YSXT - YSX Tech. Co., Ltd.
YSX Tech debuted on the market today and was halted after climbing 4.46%. The company specializes in insurance aftermarket services, software development, and scenario-based solutions targeting the Chinese insurance market.
$SOBR - SOBR Safe, Inc.
A 13G filing disclosed that Corley Thomas John has acquired a 19.5% stake in SOBR, reflecting increased interest from stakeholders.
Disclaimer: Stock Region is not responsible for any investment decisions made based on this newsletter. Always conduct your own research.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net